2026-03-12T08:11:32Z https://asahikawa-med.repo.nii.ac.jp/oai

oai:asahikawa-med.repo.nii.ac.jp:00005701 2023-06-19T12:14:57Z 7 7:24

Intramedullary Spinal Cord Metastases in Breast Cancer: Report a Case 北田, 正博 キタダ, マサヒロ 高橋, 奈七 タカハシ, ナナ 安田, 俊輔 ヤスダ, シュンスケ 岡崎, 智 オカザキ, サトシ 石橋, 圭 イシバシ, ケイ 林, 諭史 ハヤシ, サトシ Breast Cancer Intramedullary Spinal Cord Metastasis (Iscm) Brain Metastasis Background: Intramedullary spinal cord metastasis (ISCM) from breast cancer is a relatively rare disease. We present this disease. Case presentation: The patient was a 67-year-old woman with lung metastasis appearing 3 years after breast cancer surgery. Complete remission was achieved for the metastatic lesion with chemotherapy, but multiple cerebellar metastases were found 3 months after the completion of chemotherapy. Whole-brain irradiation was administered, resulting in symptomatic improvement. Approximately 6 months later, the patient experienced weakness in the lower extremities and difficulty walking. Magnetic resonance imaging detected a well-defined intraspinal tumor measuring 13 × 13 × 30 mm at the level of Th12-L1. After 20-Gy irradiation to the tumor, oral steroid administration, and rehabilitation, the patient regained the ability to walk. Eight months have passed, to date, since these interventions and the patient is currently receiving treatment for metastases to bones, including the spine, but is still capable of walking without difficulty. We herein report this case with a review of the relevant literature. Conclusion: ISCM in the breast cancer is relatively rare. But, it is the clinical condition which it should always place in the mind. text application/pdf journal article 2016-12-01 VoR application/pdf Journal of Cancer Therapy 13 7 1034 1038 2151-1934 https://asahikawa-med.repo.nii.ac.jp/record/5701/files/6765.pdf https://asahikawa-med.repo.nii.ac.jp/records/5701 eng 10.4236/jct.2016.713099